What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His primary scientific interests are in Breast cancer, Internal medicine, Oncology, Cancer and Pathology.
His Breast cancer research incorporates themes from Bevacizumab and Clinical significance.
His Internal medicine course of study focuses on Surgery and Disease and Bioinformatics.
George W. Sledge has researched Oncology in several fields, including Trastuzumab, Metastatic breast cancer, Oncotype DX, Gynecology and Docetaxel.
His Cancer research is multidisciplinary, incorporating perspectives in Cancer research, Immunology and MEDLINE.
His research in Pathology intersects with topics in Neovascularization, Antibody, Monoclonal antibody, Biomarker and Primary tumor.
His most cited work include:
- Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer (840 citations)
- Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. (751 citations)
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer (745 citations)
What are the main themes of his work throughout his whole career to date?
George W. Sledge mainly focuses on Breast cancer, Internal medicine, Oncology, Cancer and Cancer research.
His biological study spans a wide range of topics, including Surgery and Clinical trial, Disease, Pathology.
The study incorporates disciplines such as Primary tumor and Brain metastasis in addition to Pathology.
His Oncology research incorporates elements of Abemaciclib, Paclitaxel, Trastuzumab and Adjuvant therapy.
His studies deal with areas such as Cancer cell, Gene, Metastasis and Immunology as well as Cancer research.
The Metastatic breast cancer study combines topics in areas such as Docetaxel and Phases of clinical research.
He most often published in these fields:
- Breast cancer (60.58%)
- Internal medicine (57.26%)
- Oncology (49.38%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (57.26%)
- Oncology (49.38%)
- Breast cancer (60.58%)
In recent papers he was focusing on the following fields of study:
George W. Sledge spends much of his time researching Internal medicine, Oncology, Breast cancer, Cancer and Fulvestrant.
His Abemaciclib, Metastatic breast cancer and Disease study in the realm of Internal medicine interacts with subjects such as In patient.
His Oncology study combines topics in areas such as Adjuvant chemotherapy, Endocrine therapy, Chemotherapy and MEDLINE.
His work carried out in the field of Breast cancer brings together such families of science as Chemotherapy regimen, Cancer research, Clinical trial and Hazard ratio.
George W. Sledge studies Cancer, namely Advanced breast.
His Fulvestrant study integrates concerns from other disciplines, such as Clinical endpoint and Tolerability.
Between 2015 and 2021, his most popular works were:
- MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy. (536 citations)
- Integrated digital error suppression for improved detection of circulating tumor DNA (528 citations)
- The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial (173 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
George W. Sledge mainly investigates Internal medicine, Oncology, Breast cancer, Cancer and Cancer research.
His Oncology research includes elements of Taxane, Metastatic breast cancer, Disease and Cyclophosphamide.
The various areas that he examines in his Metastatic breast cancer study include Metastasis and Confidence interval.
George W. Sledge combines subjects such as Bevacizumab, Surgical oncology, Chemotherapy regimen and Hazard ratio with his study of Breast cancer.
His Cancer research is multidisciplinary, relying on both Circadian rhythm, Physiology and Polysomnography.
His Cancer research research includes themes of Whole blood, Trastuzumab, Circulating tumor cell and Monoclonal.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
